Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Clinical trial NCT01634113 · COMPLETED
Trial details
- NCT number
- NCT01634113
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-12-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.